{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:06:33Z","timestamp":1772445993565,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901694"],"award-info":[{"award-number":["81901694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305184"],"award-info":[{"award-number":["82305184"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Explorer Program","award":["21TS1400600"],"award-info":[{"award-number":["21TS1400600"]}]},{"name":"Shanghai Rising Stars of Medical Talents Youth Development Program","award":["SHWSRS(2024)_070"],"award-info":[{"award-number":["SHWSRS(2024)_070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11944-z","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T11:57:59Z","timestamp":1755777479000},"page":"1072-1083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel multi-parameter MRI-based model for identification of high-risk metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1007","volume":"36","author":[{"given":"Wenxin","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xutong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huamei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6471-6687","authenticated-orcid":false,"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"11944_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"11944_CR2","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C (2017) Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 377:2063\u20132072. https:\/\/doi.org\/10.1056\/NEJMra1503519","journal-title":"N Engl J Med"},{"key":"11944_CR3","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J et al (2017) Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology 65:1557\u20131565. https:\/\/doi.org\/10.1002\/hep.29085","journal-title":"Hepatology"},{"key":"11944_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S et al (2015) Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149:389\u2013397.e10. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043","journal-title":"Gastroenterology"},{"key":"11944_CR5","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","volume":"73","author":"BA Davison","year":"2020","unstructured":"Davison BA, Harrison SA, Cotter G et al (2020) Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J Hepatol 73:1322\u20131332. https:\/\/doi.org\/10.1016\/j.jhep.2020.06.025","journal-title":"J Hepatol"},{"key":"11944_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R et al (2021) Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int 41:261\u2013270. https:\/\/doi.org\/10.1111\/liv.14669","journal-title":"Liver Int"},{"key":"11944_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518\u2013526. https:\/\/doi.org\/10.1053\/jhep.2003.50346","journal-title":"Hepatology"},{"key":"11944_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","volume":"79","author":"M Kjaergaard","year":"2023","unstructured":"Kjaergaard M, Lindvig KP, Thorhauge KH et al (2023) Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease. J Hepatol 79:277\u2013286. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.002","journal-title":"J Hepatol"},{"key":"11944_CR9","doi-asserted-by":"publisher","first-page":"ITC65","DOI":"10.7326\/AITC201811060","volume":"169","author":"XJ Wang","year":"2018","unstructured":"Wang XJ, Malhi H (2018) Nonalcoholic fatty liver disease. Ann Intern Med 169:ITC65\u2013ITC80. https:\/\/doi.org\/10.7326\/AITC201811060","journal-title":"Ann Intern Med"},{"key":"11944_CR10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/postgradmedj-2018-136316","volume":"95","author":"E Jennison","year":"2019","unstructured":"Jennison E, Patel J, Scorletti E, Byrne CD (2019) Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J 95:314\u2013322. https:\/\/doi.org\/10.1136\/postgradmedj-2018-136316","journal-title":"Postgrad Med J"},{"key":"11944_CR11","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.25993","volume":"57","author":"J Boursier","year":"2013","unstructured":"Boursier J, Zarski JP, de Ledinghen V et al (2013) Multicentric group from ANRS\/HC\/EP23 FIBROSTAR studies. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 57:1182\u20131191. https:\/\/doi.org\/10.1002\/hep.25993","journal-title":"Hepatology"},{"key":"11944_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS et al (2023) AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77:1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"11944_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","volume":"152","author":"CC Park","year":"2017","unstructured":"Park CC, Nguyen P, Hernandez C et al (2017) Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152:598\u2013607.e2. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.026","journal-title":"Gastroenterology"},{"key":"11944_CR14","doi-asserted-by":"publisher","first-page":"e0266859","DOI":"10.1371\/journal.pone.0266859","volume":"17","author":"TA Woreta","year":"2022","unstructured":"Woreta TA, Van Natta ML, Lazo M et al (2022) Validation of the accuracy of the FAST\u2122 score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms. PLoS One 17:e0266859. https:\/\/doi.org\/10.1371\/journal.pone.0266859","journal-title":"PLoS One"},{"key":"11944_CR15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","volume":"76","author":"M Noureddin","year":"2022","unstructured":"Noureddin M, Truong E, Gornbein JA et al (2022) MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis. J Hepatol 76:781\u2013787. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.012","journal-title":"J Hepatol"},{"key":"11944_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2007.06.012","volume":"5","author":"M Yin","year":"2007","unstructured":"Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207\u20131213.e2. https:\/\/doi.org\/10.1016\/j.cgh.2007.06.012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11944_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1053\/j.gastro.2017.06.005","volume":"153","author":"MS Middleton","year":"2017","unstructured":"Middleton MS, Heba ER, Hooker CA et al (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753\u2013761. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.005","journal-title":"Gastroenterology"},{"key":"11944_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","volume":"60","author":"R Banerjee","year":"2014","unstructured":"Banerjee R, Pavlides M, Tunnicliffe EM et al (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60:69\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2013.09.002","journal-title":"J Hepatol"},{"key":"11944_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2024","unstructured":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) (2024) EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 81:492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"key":"11944_CR20","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","volume":"165","author":"JJ Wattacheril","year":"2023","unstructured":"Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ (2023) AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review. Gastroenterology 165:1080\u20131088. https:\/\/doi.org\/10.1053\/j.gastro.2023.06.013","journal-title":"Gastroenterology"},{"key":"11944_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111709","volume":"180","author":"J Liu","year":"2024","unstructured":"Liu J, Wang Z, Yu D et al (2024) Comparative analysis of hepatic fat quantification across 5 T, 3 T and 1.5 T: a study on consistency and feasibility. Eur J Radiol 180:111709. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111709","journal-title":"Eur J Radiol"},{"key":"11944_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.931231","volume":"13","author":"T Wan","year":"2022","unstructured":"Wan T, Zhu Y, Han Q, Liu L (2022) Changes in vertebral marrow fat fraction using 3D fat analysis & calculation technique imaging sequence in aromatase inhibitor-treated breast cancer women. Front Endocrinol 13:931231. https:\/\/doi.org\/10.3389\/fendo.2022.931231","journal-title":"Front Endocrinol"},{"key":"11944_CR23","unstructured":"QIBA MRE Technical Committee (2025) MRE quantitative imaging biomarkers (QIBA) profile. https:\/\/qibawiki.rsna.org\/images\/f\/f6\/MRE_QIBA_Profile-2019-06-06-CONSENSUS-maintenance.pdf"},{"key":"11944_CR24","unstructured":"Banerjee R, Pavlides M, Barnes E (2014) Method and apparatus for non-invasive detection of inflammation of a visceral organ. Patent WO2015144916A1. Available via https:\/\/patents.google.com\/patent\/WO2015144916A1\/en. Accessed 10 Feb 2025"},{"key":"11944_CR25","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467\u20132474. https:\/\/doi.org\/10.1111\/j.1572-0241.1999.01377.x","journal-title":"Am J Gastroenterol"},{"key":"11944_CR26","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321. https:\/\/doi.org\/10.1002\/hep.20701","journal-title":"Hepatology"},{"key":"11944_CR27","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cgh.2017.08.024","volume":"16","author":"P Verhaegh","year":"2018","unstructured":"Verhaegh P, Bavalia R, Winkens B et al (2018) Noninvasive tests do not accurately differentiate nonalcoholic steatohepatitis from simple steatosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 16:837\u2013861. https:\/\/doi.org\/10.1016\/j.cgh.2017.08.024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11944_CR28","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","volume":"65","author":"PS Dulai","year":"2016","unstructured":"Dulai PS, Sirlin CB, Loomba R (2016) MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice. J Hepatol 65:1006\u20131016. https:\/\/doi.org\/10.1016\/j.jhep.2016.06.005","journal-title":"J Hepatol"},{"key":"11944_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100774","volume":"28","author":"L Torres","year":"2023","unstructured":"Torres L, Schuch A, Longo L et al (2023) New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD. Ann Hepatol 28:100774. https:\/\/doi.org\/10.1016\/j.aohep.2022.100774","journal-title":"Ann Hepatol"},{"key":"11944_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12876-020-01234-x","volume":"20","author":"Y Liang","year":"2020","unstructured":"Liang Y, Li D (2020) Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy. BMC Gastroenterol 20:89. https:\/\/doi.org\/10.1186\/s12876-020-01234-x","journal-title":"BMC Gastroenterol"},{"key":"11944_CR31","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","volume":"66","author":"G Xiao","year":"2017","unstructured":"Xiao G, Zhu S, Xiao X et al (2017) Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology 66:1486\u20131501. https:\/\/doi.org\/10.1002\/hep.29302","journal-title":"Hepatology"},{"key":"11944_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2022.10.027","volume":"78","author":"W Shen","year":"2023","unstructured":"Shen W, Middleton MS, Cunha GM et al (2023) Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis. J Hepatol 78:238\u2013246. https:\/\/doi.org\/10.1016\/j.jhep.2022.10.027","journal-title":"J Hepatol"},{"key":"11944_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.29797","volume":"68","author":"C Caussy","year":"2018","unstructured":"Caussy C, Reeder SB, Sirlin CB, Loomba R (2018) Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology 68:763\u2013772. https:\/\/doi.org\/10.1002\/hep.29797","journal-title":"Hepatology"},{"key":"11944_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jhep.2020.03.032","volume":"73","author":"CA Parisinos","year":"2020","unstructured":"Parisinos CA, Wilman HR, Thomas EL et al (2020) Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis. J Hepatol 73:241\u2013251. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.032. Erratum in: J Hepatol. 2020;73:1594\u20131595. 10.1016\/j.jhep.2020.08.030","journal-title":"J Hepatol"},{"key":"11944_CR35","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.ejrad.2015.05.019","volume":"84","author":"C Cassinotto","year":"2015","unstructured":"Cassinotto C, Feldis M, Vergniol J et al (2015) MR relaxometry in chronic liver diseases: comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 84:1459\u20131465. https:\/\/doi.org\/10.1016\/j.ejrad.2015.05.019","journal-title":"Eur J Radiol"},{"key":"11944_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.rcl.2022.04.003","volume":"60","author":"CL Welle","year":"2022","unstructured":"Welle CL, Olson MC, Reeder SB, Venkatesh SK (2022) Magnetic resonance imaging of liver fibrosis, fat, and iron. Radiol Clin North Am 60:705\u2013716. https:\/\/doi.org\/10.1016\/j.rcl.2022.04.003","journal-title":"Radiol Clin North Am"},{"key":"11944_CR37","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00261-021-03378-0","volume":"47","author":"N Mahalingam","year":"2022","unstructured":"Mahalingam N, Trout AT, Gandhi DB et al (2022) Associations between MRI T1 mapping, liver stiffness, quantitative MRCP, and laboratory biomarkers in children and young adults with autoimmune liver disease. Abdom Radiol (NY) 47:672\u2013683. https:\/\/doi.org\/10.1007\/s00261-021-03378-0. Erratum in: Abdom Radiol. 2022;47:1511. 10.1007\/s00261-022-03437-0","journal-title":"Abdom Radiol (NY)"},{"key":"11944_CR38","doi-asserted-by":"publisher","unstructured":"Imajo K, Saigusa Y, Kobayashi T et al (2024) Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-024-11215-3","DOI":"10.1007\/s00330-024-11215-3"},{"key":"11944_CR39","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/jmri.28040","volume":"56","author":"S Alsaqal","year":"2022","unstructured":"Alsaqal S, Hockings P, Ahlstr\u00f6m H et al (2022) The combination of MR elastography and proton density fat fraction improves diagnosis of nonalcoholic steatohepatitis. J Magn Reson Imaging 56:368\u2013379. https:\/\/doi.org\/10.1002\/jmri.28040","journal-title":"J Magn Reson Imaging"},{"key":"11944_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ et al (2020) FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol 5:362\u2013373. https:\/\/doi.org\/10.1016\/S2468-1253(19)30383-8. Erratum in: Lancet Gastroenterol Hepatol 2020;5:e3. 10.1016\/S2468-1253(20)30055-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11944_CR41","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/jgh.16589","volume":"39","author":"S Qi","year":"2024","unstructured":"Qi S, Wei X, Zhao J et al (2024) Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction-associated steatohepatitis. J Gastroenterol Hepatol 39:1656\u20131662. https:\/\/doi.org\/10.1111\/jgh.16589","journal-title":"J Gastroenterol Hepatol"},{"key":"11944_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-020-00505-z","volume":"20","author":"R Obuchowicz","year":"2020","unstructured":"Obuchowicz R, Oszust M, Piorkowski A (2020) Interobserver variability in quality assessment of magnetic resonance images. BMC Med Imaging 20:109. https:\/\/doi.org\/10.1186\/s12880-020-00505-z","journal-title":"BMC Med Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11944-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11944-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:25:23Z","timestamp":1772443523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11944-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["11944"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11944-z","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Jie Yuan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Wenxin Ma, Xutong Huang, Zhen Feng, Wenli Tan, Jinzhe Li, Huamei Yan, Yanxi Zheng, Fuhua Yan, Huimin Lin, and Jie Yuan declare no conflicts of interest related to this manuscript. Zhiwei Qin reports no conflicts of interest in this study but discloses his employment with Shanghai United Imaging Healthcare Co., Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Dr Huamei Yan provided statistical advice for this manuscript. She is a biostatistician at Clinical Research Center\u2019s Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, and is one of the authors of our study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported in the literature.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}